Johnson & Johnson Says Its Booster Shot Provides Increased Protection From COVID-19
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
People who receive a Johnson & Johnson COVID-19 vaccine booster shot are better protected against the coronavirus for a longer period of time, according to the pharmaceutical company's latest trial results.
The one-dose Johnson & Johnson vaccine to be 66% protective against moderate and severe disease overall worldwide and 72% protective against such cases in the U.S. But when a person receives
